Jazz Pharmaceuticals (JAZZ)

[MiamiGent]

JAZZ Jazz Pharmaceuticals Gains on Xyrem Court Ruling
BY DJ Realtime News 12:40 PM ET 09/17/2012

http://stockcharts.com/h-sc/ui?s=JAZZ

Shares of Jazz Pharmaceuticals PLC (JAZZ) jumped 13.2% to $54.47 recently following news that a federal court has issued a Markman ruling largely in favor of Jazz on its narcolepsy medication Xyrem.

"The judge in the Xyrem patent case just issued the long awaited Markman ruling that defines the patent claim terms," wrote Jefferies analyst Corey Davis in his note Monday.

"In our initial read, we count 17 occurrences of agreeing with the Jazz construction and zero occurrences of agreement with Roxane [Laboratories]. We have not had a chance to fully review the 43 page ruling, but at first blush this seems like a clear win for Jazz," Davis added.

Jazz's stock has climbed approximately 12% over the past 30 days and over 41% year-to-date.

Write to Val Brickates Kennedy at [e-mail]